Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer02:18

Cancer

51.8K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.8K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.7K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.7K
Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Malignant peripheral nerve sheath tumor of the right forearm: Case report.

International journal of surgery case reports·2025
Same author

Thoracic Endovascular Aortic Repair (TEVAR) for Grade III Traumatic Thoracic Aortic Injury.

Cureus·2025
Same author

An Unusual Paraganglioma of the Left Vagus Nerve: A Surgical Conundrum.

Cureus·2025
Same author

Giant Uterine Tumor Compatible With Sarcoma.

Cureus·2025
Same author

Giant Frontoethmoidal Encephalocele in an Infant: A Case Report.

Cureus·2025

Related Experiment Video

Updated: May 7, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.8K

Two Simultaneous Primary Cancers: A Case Report.

Catalina Gonzalez Aguirre1, Elias Gallardo-Navarro2, Antonio Castillo Magaña3

  • 1Oncologic Surgery, Spanish Hospital, Mexico City, MEX.

Cureus
|May 12, 2025
PubMed
Summary

A patient initially diagnosed with neck sarcoma developed a second, distinct tumor in the testicle. This case highlights the importance of thorough staging and histological confirmation for identifying multiple primary neoplasms.

Keywords:
head and neck neoplasmsmultiple primary tumorsprimary testicular lymphomasoft tissue sarcomasynchronous tumor

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

179
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

378

Related Experiment Videos

Last Updated: May 7, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

1.8K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

179
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

378

Area of Science:

  • Oncology
  • Pathology

Background:

  • Multiple primary neoplasms present a diagnostic challenge, requiring differentiation from metastatic disease.
  • Accurate staging and histological confirmation are crucial for appropriate patient management.

Observation:

  • A patient with undifferentiated pleomorphic sarcoma (UPS) of the neck underwent staging scans prior to systemic therapy.
  • Positron emission tomography (PET) revealed unexpected tumor activity in the left testicle.

Findings:

  • Radical orchiectomy confirmed a second primary neoplasm: non-Hodgkin lymphoma (NHL) B cells.
  • The distinct histology and site of the testicular tumor made metastasis from the primary neck sarcoma unlikely.

Implications:

  • This case underscores the necessity of comprehensive diagnostic workups when encountering unexpected findings during cancer staging.
  • Recognizing multiple primary tumors is vital for tailoring effective, individualized treatment strategies.
  • Further investigation into the co-occurrence of UPS and NHL may yield insights into shared oncogenic pathways.